NeuroOne Medical Technologies
NMTC
14 hedge funds and large institutions have $1.13M invested in NeuroOne Medical Technologies in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.09% less ownership
Funds ownership: 0.98% → 0.89% (-0.09%)
7% less funds holding
Funds holding: 15 → 14 (-1)
27% less capital invested
Capital invested by funds: $1.55M → $1.13M (-$423K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.53K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DWM
Drive Wealth Management
Lehi,
Utah
|
-$55.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.22K |
| 3 |
SG Americas Securities
New York
|
-$4.6K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$397 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $528K | -$6.22K | -768 | -1% |
|
|
MC
2
Mayo Clinic
Rochester,
Minnesota
| $218K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $155K | +$19.8K | +2,441 | +13% |
|
|
4
SG Americas Securities
New York
| $65K | -$4.6K | -568 | -6% |
|
|
MCM
5
MAI Capital Management
Independence,
Ohio
| $60K | – | – | – |
|
6
State Street
Boston,
Massachusetts
| $43.1K | – | – | – |
|
7
Northern Trust
Chicago,
Illinois
| $23.9K | – | – | – |
|
|
PGAM
8
Princeton Global Asset Management
Princeton,
New Jersey
| $20.2K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $12.3K | +$6.53K | +806 | +90% |
|
|
NRG
10
Nemes Rush Group
Novi,
Michigan
| $520 | +$583 | +72 | New |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $420 | – | – | – |
|
|
12
Wells Fargo
San Francisco,
California
| $143 | +$16 | +2 | +11% |
|
13
UBS Group
Zurich,
Switzerland
| $130 | – | – | – |
|
|
DWM
14
Drive Wealth Management
Lehi,
Utah
| – | -$55.4K | -5,730 | Closed |
|
|
FIA
15
FNY Investment Advisers
New York
| – | -$3K | -333 | Closed |
|
|
16
Simplex Trading
Chicago,
Illinois
| – | -$397 | -49 | -91% |
|
NMTC Hedge Fund Activity: Q2 2023 in Review
14 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q2 2023, worth a combined $1.13M — down 27% from $1.55M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NMTC and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was Geode Capital Management, adding an estimated $19.8K. The largest seller was Drive Wealth Management, exiting entirely with an estimated $55.4K sold.
- 14 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q2 2023, down from 15 in Q1 2023.
- Funds reported $1.13M of NeuroOne Medical Technologies stock for Q2 2023, down 27% quarter-over-quarter.
- 1 fund opened new NeuroOne Medical Technologies positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest NeuroOne Medical Technologies buyer in Q2 2023 was Geode Capital Management, an estimated $19.8K added.
- The largest NeuroOne Medical Technologies seller in Q2 2023 was Drive Wealth Management, an estimated $55.4K sold.
Based on aggregated 13F filings for Q2 2023.